专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2004106329A3 NOVEL ANTIINFECTIVE COMPOUNDS AND THEIR PHARMACEUTICAL COMPOSITIONS 审中-公开
公开(公告)号：WO2004106329A3
公开(公告)日：2004-12-09
申请号：PCT/IB2004/001811
申请日：2004-06-03
申请人： DR. REDDY'S LABORATORIES LTD. , MOHAMED, Takhi , DAS, Jagattaran , NATESAN, Selvakumar , TREHAN, Sanjay , IQBAL, Javed , MAGADI, Sitaram, Kumar
发明人： MOHAMED, Takhi , DAS, Jagattaran , NATESAN, Selvakumar , TREHAN, Sanjay , IQBAL, Javed , MAGADI, Sitaram, Kumar
IPC分类号： C07D405/14
摘要： The present invention provides novel triazole compounds of formula (I), their pharmaceutically acceptable salts and their pharmaceutical compositions, where all symbols are as defined in the specification

2. 发明申请

WO2005082892A2 NOVEL TRIAZOLE COMPOUNDS AS ANTIBACTERIAL AGENTS AND THEIR PHARMACEUTICAL COMPOSITIONS CONTAINING THEM 审中-公开
标题翻译：新型三唑化合物作为抗菌剂及其含有它们的药物组合物
公开(公告)号：WO2005082892A2
公开(公告)日：2005-09-09
申请号：PCT/IB2005/000343
申请日：2005-02-11
申请人： DR. REDDY'S LABORATORIES LTD. , DAS, Jagattaran , TAKHI, Mohamed , NATESAN, Selvakumar , TREHAN, Sanjay , IQBAL, Javed , MAGADI, Sitaram Kumar , KANDEPU, Sreenivas
发明人： DAS, Jagattaran , TAKHI, Mohamed , NATESAN, Selvakumar , TREHAN, Sanjay , IQBAL, Javed , MAGADI, Sitaram Kumar , KANDEPU, Sreenivas
IPC分类号： C07D403/00
CPC分类号： C07D403/06 , C07D249/06 , C07D401/10 , C07D401/14 , C07D403/12 , C07D405/12 , C07D405/14 , C07D413/12
摘要： The present invention relates to novel triazole compounds of formula (I), where all symbols are as defined in the detailed description; their pharmaceutically acceptable salts their stereosiomers thereof, their prodrugs, their rotamers, their pharmaceutical compositions containing them. The present invention also relates to a process for the preparation of the above said novel compounds.
摘要翻译：本发明涉及新的式（I）三唑化合物，其中所有符号如详细描述中所定义; 其药学上可接受的盐，它们的立体异构体，它们的前药，它们的旋转异构体，它们含有它们的药物组合物。本发明还涉及制备上述新化合物的方法。

3. 发明申请

WO2005035528A2 NOVEL TRIAZOLE COMPOUNDS: PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM 审中-公开
标题翻译：新型三唑化合物：其制备方法及含有它们的药物组合物
公开(公告)号：WO2005035528A2
公开(公告)日：2005-04-21
申请号：PCT/IB2004/003360
申请日：2004-10-14
申请人： Dr. Reddy's Laboratories Ltd. , NATESAN, Selvakumar , DAS, Jagattaran , TAKHI, Mohamed , TREHAN, Sanjay , IQBAL, Javed , MAGADI, Sitaram, Kumar , KANDEPU, Sreenivas
发明人： NATESAN, Selvakumar , DAS, Jagattaran , TAKHI, Mohamed , TREHAN, Sanjay , IQBAL, Javed , MAGADI, Sitaram, Kumar , KANDEPU, Sreenivas
IPC分类号： C07D403/10
CPC分类号： C07D401/14 , C07D403/10
摘要： The present invention relates to novel triazole compounds of formula (I), their prodrugs, their pharmaceutically acceptable salts and their stereoisomers thereof. The present invention also relates to a process for the preparation of the novel compound of the formula (I).
摘要翻译：本发明涉及式（I）的新型三唑化合物，其前药，其药学上可接受的盐及其立体异构体。本发明还涉及制备式（I）的新型化合物的方法。

4. 发明申请

WO2004101531A1 ANTIINFECTIVE 1,2,3-TRIAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM 审中-公开
标题翻译：抗生素1,2,3-三唑衍生物及其制备方法及含有它们的药物组合物
公开(公告)号：WO2004101531A1
公开(公告)日：2004-11-25
申请号：PCT/IB2004/001303
申请日：2004-04-29
申请人： DR. REDDY'S LABORATORIES LTD. , DAS, Jagattaran , NATESAN, Selvakumar , TREHAN, Sanjay , IQBAL, Javed , MAGADI, Sitaram, Kumar
发明人： DAS, Jagattaran , NATESAN, Selvakumar , TREHAN, Sanjay , IQBAL, Javed , MAGADI, Sitaram, Kumar
IPC分类号： C07D249/06
CPC分类号： C07D249/08 , C07D403/10
摘要： The present invention relates to novel triazole compounds of formula (I), thie pharmaceutically acceptable salts and their pharmaceutical compositions, where all symbols have meaning as defined in the description, for use in the treatment of bacterial infections.
摘要翻译：本发明涉及式（I）的新型三唑化合物，其药学上可接受的盐及其药物组合物，其中所有符号具有如说明书中定义的含义，用于治疗细菌感染。

5. 发明申请

WO2011070592A3 NOVEL SUGAR DERIVATIVES AS SGLT2 INHIBITORS 审中-公开
公开(公告)号：WO2011070592A3
公开(公告)日：2011-06-16
申请号：PCT/IN2010/000796
申请日：2010-12-09
申请人： PANACEA BIOTEC LTD. , JAIN, Rajesh , TREHAN, Sanjay , THUNGATHURTHI, Sastry V.R.S. , NANDA, Gurmeet, Kaur , DAS, Jagattaran , MAGADI, Sitaram, Kumar , SHARMA, Sudhir, Kumar
发明人： JAIN, Rajesh , TREHAN, Sanjay , THUNGATHURTHI, Sastry V.R.S. , NANDA, Gurmeet, Kaur , DAS, Jagattaran , MAGADI, Sitaram, Kumar , SHARMA, Sudhir, Kumar
IPC分类号： C07H15/203 , C07D309/10
摘要： The present invention relates to novel compounds of Formula (I), their pharmaceutically acceptable derivatives, analogs, tautomeric forms, isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to the processes for the synthesis of novel compounds of Formula I, their pharmaceutically acceptable derivatives, analogs, tautomeric forms, isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The present invention also provides pharmaceutical compositions comprising novel compounds of Formula I and methods of treating or preventing one or more conditions or diseases that may be regulated or normalized via inhibition of Sodium Glucose Cotransporter-2 (SGLT-2). The invention also relates to the use of compounds of Formula I, their pharmaceutically acceptable derivatives, analogs, tautomeric forms, isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof, for the manufacture of a medicament for the prophylaxis, amelioration and/or treatment of conditions or diseases that may be regulated or normalized via inhibition of Sodium Glucose Cotransporter-2 (SGLT-2) and the related diseases, disorders and conditions, in a subject in need thereof.

6. 发明申请

WO2010058423A9 NOVEL ANTIMICROBIALS 审中-公开
公开(公告)号：WO2010058423A9
公开(公告)日：2010-05-27
申请号：PCT/IN2009/000658
申请日：2009-11-18
申请人： PANACEA BIOTEC LTD. , JAIN, Rajesh , TREHAN, Sanjay , DAS, Jagattaran , KANWAR, Sandeep , MAGADI, Sitaram, Kumar , SHARMA, Sudhir, Kumar
发明人： JAIN, Rajesh , TREHAN, Sanjay , DAS, Jagattaran , KANWAR, Sandeep , MAGADI, Sitaram, Kumar , SHARMA, Sudhir, Kumar
IPC分类号： C07D413/10 , C07D413/14
摘要： The present invention relates to novel phenyl oxazolidinone compounds of formula I, their pharmaceutically acceptable analogs, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to the processes for the synthesis of novel compounds of formula I or their pharmaceutically acceptable analogs, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The present invention also provides pharmaceutical compositions comprising novel compounds of formula I and methods of using them. The compounds of the present invention are useful as antimicrobial agents, effective against a number of aerobic and/or anaerobic Gram positive and/or Gram negative pathogens such as multi drug resistant species of Staphylococcus, Streptococcus, Enterococcus, Bacterioides, Clostridia, H. influenza, Moraxella, acid-fast organisms such as Mycobacterium tuberculosis as well as Linezolid resistant species of Staphylococcus and Enterococcus.

7. 发明申请

WO2010150281A2 NOVEL AZABICYCLOHEXANES 审中-公开
标题翻译：新的雅各布
公开(公告)号：WO2010150281A2
公开(公告)日：2010-12-29
申请号：PCT/IN2010/000428
申请日：2010-06-22
申请人： PANACEA BIOTEC LTD. , JAIN, Rajesh , TREHAN, Sanjay , DAS, Jagattaran , KAUR, Gurmeet , KANWAR, Sandeep , SINGH, Nishan , NANDA, Gurmeet Kaur , MAGADI, Sitaram Kumar , SHARMA, Sudhir Kumar
发明人： JAIN, Rajesh , TREHAN, Sanjay , DAS, Jagattaran , KAUR, Gurmeet , KANWAR, Sandeep , SINGH, Nishan , NANDA, Gurmeet Kaur , MAGADI, Sitaram Kumar , SHARMA, Sudhir Kumar
IPC分类号： C07D221/22 , C07D401/10 , C07D413/10 , C07D413/14 , C07D417/10 , C07D471/04 , C07D491/08 , A61K31/46 , A61K31/496 , A61K31/498 , A61K31/5355 , A61K31/551 , C07D487/04 , A61P25/00 , A61P31/00
CPC分类号： C07D221/22 , C07D209/52 , C07D401/10 , C07D409/04 , C07D413/10 , C07D413/14 , C07D417/10 , C07D417/14 , C07D471/04 , C07D487/04 , C07D491/08
摘要： The present invention relates to novel compounds of Formula (I), their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers including R and S isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to processes for the synthesis of novel compounds of Formula I, their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof.
摘要翻译：本发明涉及式（I）的新化合物，其药学上可接受的衍生物，互变异构体，立体异构体，包括R和S异构体，多晶型物，前药，代谢物，盐或溶剂化物。本发明还涉及合成式I的新化合物，其药学上可接受的衍生物，互变异构体形式，立体异构体，多晶型物，前药，代谢物，盐或溶剂合物的方法。

8. 发明申请

WO2009116090A3 NOVEL ANTIMICROBIALS 审中-公开
公开(公告)号：WO2009116090A3
公开(公告)日：2009-09-24
申请号：PCT/IN2009/000184
申请日：2009-03-17
申请人： PANACEA BIOTEC LIMITED , JAIN, Rajesh , TREHAN, Sanjay , DAS, Jagattaran , KANWAR, Sandeep , MAGADI, Sitaram, Kumar
发明人： JAIN, Rajesh , TREHAN, Sanjay , DAS, Jagattaran , KANWAR, Sandeep , MAGADI, Sitaram, Kumar
IPC分类号： C07F9/6571 , C07F9/6509 , C07F9/6584 , C07F9/6558
摘要： The present invention relates to novel phenyl oxazolidinone compounds of Formula I, their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers including R and S isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to the processes for the synthesis of novel compounds of Formula I, their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The present invention also provides pharmaceutical compositions comprising novel compounds of Formula I and methods of treating or preventing conditions caused by microbial infections. The compounds of the present invention are effective against a number of aerobic and/or anaerobic Gram positive and/or Gram negative pathogens such as multi drug resistant Staphylococcus spp., Streptococcus spp., Enterococcus spp., Bacterioides spp., Clostridia spp., H. influenza , Moraxella Spp., as well as acid-fast organisms such as Mycobacterium tuberculosis and the like.

9. 发明申请

WO2009093269A9 NOVEL HETEROCYCLIC COMPOUNDS 审中-公开
公开(公告)号：WO2009093269A9
公开(公告)日：2009-07-30
申请号：PCT/IN2009/000061
申请日：2009-01-23
申请人： PANACEA BIOTEC LIMITED , JAIN, Rajesh , TREHAN, Sanjay , DAS, Jagattaran , SINGH, Nishan , NANDA, Gurmeet Kaur , MAGADI, Sitaram Kumar , SHARMA, Sudhir Kumar
发明人： JAIN, Rajesh , TREHAN, Sanjay , DAS, Jagattaran , SINGH, Nishan , NANDA, Gurmeet Kaur , MAGADI, Sitaram Kumar , SHARMA, Sudhir Kumar
IPC分类号： C07D243/14 , C07D403/06 , C07D413/12 , C07D487/04 , A61K31/551 , A61P3/10
摘要： The present invention relates to novel compounds of Formula I, their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers including R and S isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to the processes for the synthesis of novel compounds of Formula I, their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The present invention also provides pharmaceutical compositions comprising compounds of Formula I and methods of treating or preventing one or more conditions that may be regulated or normalized via inhibition of dipeptidyl peptidase IV (DPP-IV). Formula I

10. 发明申请

WO2008090570A1 NOVEL ANTIMICROBIALS 审中-公开
标题翻译：新的抗生素
公开(公告)号：WO2008090570A1
公开(公告)日：2008-07-31
申请号：PCT/IN2008/000047
申请日：2008-01-24
申请人： PANACEA BIOTEC LTD , JAIN, Rajesh , TREHAN, Sanjay , DAS, Jagattaran , KAUR, Gurmeet , KANWAR, Sandeep , MAGADI, Sitaram, Kumar
发明人： JAIN, Rajesh , TREHAN, Sanjay , DAS, Jagattaran , KAUR, Gurmeet , KANWAR, Sandeep , MAGADI, Sitaram, Kumar
IPC分类号： C07F9/6584 , C07D413/10 , A61K31/495
CPC分类号： C07F9/6584
摘要： The present invention relates to novel phenyl oxazolidinone compounds of formula (I) or their pharmaceutically acceptable analogs, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to the processes for the synthesis of novel compounds of formula (I) or their pharmaceutically acceptable analogs, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The present invention also provides pharmaceutical compositions comprising novel compounds of formula I and methods of using them. The compounds of the present invention are useful as antimicrobial agents, effective against a number of aerobic and/or anaerobic Gram positive and/or Gram negative pathogens such as multi drug resistant Staphylococcus spp., Streptococcus spp., Enterococcus spp., Bacterioides spp., Clostridia spp., H. influenza , Moraxella Spp., as well as acid-fast organisms such as Mycobacterium tuberculosis and the like.
摘要翻译：本发明涉及式（I）的新的苯基恶唑烷酮化合物或其药学上可接受的类似物，互变异构形式，立体异构体，多晶型物，前药，代谢物，盐或溶剂合物。本发明还涉及合成式（I）的新型化合物或其药学上可接受的类似物，互变异构形式，立体异构体，多晶型物，前药，代谢物，盐或溶剂合物的方法。本发明还提供了包含新颖的式I化合物和使用它们的方法的药物组合物。本发明的化合物可用作抗微生物剂，对多种需氧和/或厌氧革兰氏阳性和/或革兰氏阴性病原体有效，如多药耐药葡萄球菌，链球菌属，肠球菌属，细菌属，，梭菌属（Clostridia spp。），流感嗜血杆菌（H. influenza），莫拉氏菌（Moraxella Spp。）以及耐酸生物如结核分枝杆菌等。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式